Press Releases

TissueTech Partners with Donate Life America to Raise Public Awareness about the Importance of Tissue Donation

Leader in regenerative medicine joins forces with advocates to spread awareness on the role tissue donation can play in restoring quality of life and improved health Miami, FL – April 19, 2021 – TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today that it […]

TissueTech Receives FDA Clearance to Proceed with Phase 1 Clinical Study using Investigational New Drug TTAX03 to Treat Facet Joint Osteoarthritis Pain

Amniox Medical

Investigators will evaluate the dosage and safety of Cryopreserved Amniotic Membrane and Cryopreserved Umbilical Cord TTAX03 for pain relief and functional improvement of facet joint osteoarthritis in the lumbosacral region Miami, FL – March 8, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based […]

TissueTech Receives U.S. Food and Drug Administration Clearance to Proceed with Clinical Study using Investigational New Drug TTBT01

Bio-Tissue

Regenerative medicine research pioneer takes the first step towards commercializing human birth tissue-based biologic products for the treatment of ocular surface disease and disorders Miami, FL – March 1, 2021 – Bio-Tissue, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that its parent company TissueTech […]

Bio-Tissue Expands Health Plan Geographic Footprint in Pennsylvania for Reimbursement Coverage of PROKERA Biologic Corneal Bandage

Bio-Tissue

Highmark Blue Cross Blue Shield joins the ranks of the more than 90 percent of commercial health plans who already offer reimbursement coverage for PROKERA Cryopreserved Amniotic Membrane Miami, FL – February 17, 2021 – Bio-Tissue, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that […]

TissueTech to be Featured on Behind the Scenes with Host Laurence Fishburne

New episode focuses on how TissueTech’s human birth tissue products are redefining regenerative medicine by helping repair and restore diseased or damaged cells   Miami, FL – January 4, 2021 – TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today that its products will […]

TissueTech Appoints Denise Spencer Vice President of Human Resources

Change champion will focus on aligning associates with organization’s mission, vision, and values in accordance with strategic business objectives Miami, FL – December 7, 2020 – TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today that Denise Spencer, MBA and Senior Professional in Human […]

Newly Published Study Results Show that Patients with Infectious Corneal Ulcers had Significantly Faster Epithelialization and better Visual Acuity than Standard of Care (SOC) After Receiving Placement of Cryopreserved Amniotic Membrane

Bio-Tissue

Post-treatment application of Cryopreserved Amniotic Membrane (PROKERA® Slim) may be useful in treating sight-threatening infectious corneal ulcers by promoting faster corneal epithelialization and overall better recovery of Visual Acuity Miami, FL – November 19, 2020 – Bio-Tissue, Inc. (Bio-Tissue), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products for […]

TissueTech Announces Engagement of Pro-ficiency Virtual Study Trainer™ for Clinical Trials

Miami, FL – November 19, 2020 – TissueTech, Inc., an emerging biotechnology company and pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today the engagement of Pro-ficiency Virtual Study Trainer™ to facilitate remote study protocol training for TissueTech’s clinical trial investigators and their clinical research teams. TissueTech […]

Amniox Launches Virtual Education and Diabetic Foot Ulcer Outreach Campaign to Support National Diabetes Month

Amniox Medical

Month-long campaign features a host of educational activities focusing on management of complex, chronic wounds resulting from diabetes Miami, FL – November 10, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that it had joined forces with key stakeholder groups […]

Recently Published Study Suggests CLARIX FLO Amniotic Membrane/Umbilical Cord Particulate Provides Benefits in Moderate to Severe Knee Osteoarthritis

Amniox Medical

74% of patients treated with CLARIX® FLO demonstrated clinically significant improvement at 12 months, signifying its potential in delaying Total Knee Arthroplasty (TKA) Miami, FL – November 9, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from a […]

Archives

  • 2021
  • 2020
  • 2019
  • 2018